Introduction
Kidney ischemia is the most common disturbance in clinic, accompanied with renal failure (1) . However, still there is no practical sufficient solution for amelioration of acute renal failure (ARF) as a consequence of ischemia reperfusion injury (IRI) (2, 3) . Usually, a decrease in renal blood for several minutes and then restoration of the blood flow may result in ARF (4, 5) . ARF is seen in different conditions such as gut ischemia (5) , cardiopulmonary bypass (6) , myocardial infarction (7) and stroke (8) . Moreover, IRI plays a major role in short or long-term graft rejection in organ transplantations (5, 9, 10) . It is reported that slight changes in total renal blood flow may lead to anoxic injury in the medulla, tubular dysfunction, salt wasting, and glomerular vasoconstriction (11, 12) . IRI also may disturb other organs such as circulatory (13) and pulmonary systems (14, 15) ; therefore, it shows the complexity of the systemic response to kidney IRI (15) . As IRI is a major cause of mortality, it is important to find a way for reducing harmful metabolites induced during IRI. Nitric oxide (NO) is an important molecule both in physiological and pathophysiological conditions (16) (17) (18) . NO is synthesized from L-arginine, and this free radical is produced from three isoforms of NO synthase (NOS). The inducible NOS (iNOS) can be produced in the kidney (19, 20) by inducible factors; cytokines and lipopolysaccharide (21, 22) . It is reported that under IRI condition, the renal cell can induce iNOS (18) . Although NO has important roles in the homeostatic regulation of glomerular, vascular, and tubular functions (23) (24) (25) (26) (27) , the excessive amount of NO result in pathophysiological conditions especially in IRI, and excessive NO worsens renal injury during ischemia. Accordingly, iNOS inhibition may improve or prevent destructive effects of IRI (28) (29) (30) (31) . A study indicated that S-methylisothiourea (SMT), an iNOS inhibitor, plays differential roles in sepsis-associated multiple organ dysfunctions (32, 33) .
Objectives
We hypothesized that SMT may protect the kidney against IRI. To confirm this hypothesis, SMT was administered 2 hour before ischemia then the kidney was perfused for 24 hours.
Materials and methods

Animals
Male Wistar rats weighting 160-220 g were housed at the room temperature of 23-25°C with a 12-hour light/dark cycle. The rats were fed with rat chow and water ad libitum. The experiment protocol was in advance approved by the Isfahan University of Medical Sciences Ethics Committee.
Experimental protocol
The rats were randomly assigned to IRI (group 2, n = 7) and IR + SMT group (group 3, n = 5). At the first day of the experiment, the animals in these groups received a single dose of saline or SMT (50 mg/kg), respectively, 2 hours prior to ischemia. SMT was purchased from Sigma (St. Louis, Missouri, USA). To induce ischemia, all the rats were anesthetized with the mixture of xylazine (10 mg/kg, i.p) and ketamine (75 mg/kg, i.p). Incisions were made and the kidneys were excised with care. The renal artery and vein were occluded in both kidneys by placing a clamp around the vessels for 45 minutes. Then, the clamp was removed with care to make sure that blood flows into the kidneys. The same surgical procedure was done on the animals in group 1 except clamping the vessels. The animals were kept in the animal room and 24 hours later, they were anesthetized again to obtain blood sample by heart puncture and then sacrificed. The kidneys were removed rapidly for histology procedures and measurement. The left kidney was fixed in 10% formalin solution, embedded in paraffin for histopathological staining. The hematoxylin and eosin staining was applied to examine the tissue injury. To consider the kidney damage, the pathologist evaluated presence of tubular atrophy, hyaline casts, ischemic necrosis, vacuolization, and debris. The damages were scored from 1-4, where 0 was assigned to normal tissue. The right kidney was homogenized, and centrifuged at 6000 g for 10 minutes. The supernatant was removed and the sample was centrifuged again at 15 000 g for 2 minutes for measuring selected biochemical parameters.
Measurements
Serum creatinine (Cr) and blood urea nitrogen (BUN) levels were determined using quantitative kits (Pars Azmoon, Iran) and autoanalyzer (Technicon, RA1000). Levels of nitrite (stable NO metabolite) in the serum and kidney were measured using a colorimetric assay kit. The serum level of malondialdehyde (MDA) was quantified according to the manual method.
Statistical analysis
The data are presented as mean ± standard error of the mean. The groups were compared with each other by one-way analysis of variance (ANOVA), followed by the least significant difference (LSD) with regard to the serum levels of BUN, Cr, nitrite, and MDA; and kidney tissue levels of MDA and nitrite, kidney weight (KW), and bodyweight (BW) changes. The Mann-Whitney or Kruskal-Wallis tests were used to compare the pathological damage score of the groups. P < 0.05 was considered statistically significant.
Results
Effect of IR or IR + SMT on serum BUN and Cr levels
The serum levels of BUN and Cr significantly increased in the control group (IR + saline) (P < 0.05). However, administration of SMT did not decrease the serum levels of Cr and BUN toward normal. The serum levels of BUN and Cr in IR + SMT group (group 3) was significantly higher than those in the control group (P < 0.05). This data did not show any protective role of SMT against kidney IRI (Figure 1 ).
Effect of IR or IR + SMT on kidney weight and damage
The KW significantly increased in IR + saline and IR + SMT groups when compared with the sham-operated group (P < 0.05). The results of renal histopathology demonstrated significant increase of tissue damage in IR + saline and IR + SMT groups compared with the shamoperated group (P < 0.05). In addition, this result shows that administration of SMT can lead to further damage in kidney in addition to the renal IRI (Figure 1 ).
Effect of IR or IR + SMT on serum MDA and nitrite levels
The nitrite levels in the serum and kidney tissue of IR + saline and IR + SMT groups were higher than those in the sham-operated group. However, this increase was statistically significant for kidney tissue (P < 0.05). The groups were not significantly different in terms of serum and kidney tissue levels of MDA (Figure 2) .
Discussion
In the current study, we investigated the effect of SMT, a potent and selective iNOS inhibitor, on renal IRI. Renal IRI induced ARF in animal model, which is characterized by increase in serum BUN and Cr levels, KW, and KTDS. Other findings were in agreement with these observations (34, 35) . During IRI reactive oxygen species are produced and alter tubular permeability, which result in tubular damage, glomerular injury, and renal dysfunction (36) (37) (38) . Shoskes et al showed 60 minutes of ischemia followed by 2 hours of reperfusion increased NOS activity (39) . Some evidence has shown excessive NO production during IRI is related to renal dysfunction (39, 40) . Administration of SMT promoted renal damage induced by IRI. Contrary to our findings, Guven et al showed that administration of SMT 6 hours prior to renal ischemia followed by 6 hours of reperfusion ameliorated renal dysfunction (33) . This contrast may be related to the different protocols used. Although reperfusion is necessary for survival in ischemic kidney, it leads to further injury in the tissue (41, 42) probably due to distribution of harmful metabolites (4, 43) . In the present study, renal reperfusion was achieved for 24 hours that may lead to further injury. Administration of SMT increased lipid peroxidation and hepatic injury, however, it seems that NO has cytoprotective and cytotoxic roles. For example, L-Arg as the NO donor ameliorates cisplatin-induced nephrotoxicity in male rats (44, 45) , and S-Nitroso-N-acetylpenicillamine (SNAP) as another NO donor abolished hepatic injury (45) while L-NAME as the NO inhibitor accelerated nephrotoxicity induced by cisplatin (46) . Inhibition of NO by SMT reduced renal dysfunction induced by IRI (33). Hsu et al reported the protective effect of iNOS in hepatic IRI, which was proved via NO donor effect on increment of iNOS activity and consequent decrement of MDA level (45) . It seems that in our study, SMT inhibited beneficial effect of iNOS. On the other hand, in this study, despite inhibition of iNOS, SMT did not decrease kidney nitrite level. It is reported that iNOS and eNOS participate in production of nitrite during IRI (40) . Therefore, increased kidney NO level in SMT-treated group possibly originated from eNOS. Our findings showed that SMT reduced the enhanced serum NO induced by IRI, although it was not significant. Other investigations demonstrated decrement in plasma nitrite/nitrate levels by iNOs inhibitors (30) . They indicated that iNOS inhibitors reduce peroxynitrite formation possibly due to inhibition of iNOS activity, which in turn led to decreased NO levels. Finally, the increased KW by IRI is probably related to edema and renal cell proliferation (40, 47) and SMT did not affect it.
Conclusion
ARF due to IRI is a complex disorder which is involved many physiology and pathology pathways including NO system that need to be determined. NOS inhibition by SMT during IRI increased kidney injury possibly due to disturbance of renal blood flow and oxidative stress.
